Mr. Dan Legault reports

ANTIBE THERAPEUTICS REPORTS Q3 2015 INTERIM FINANCIAL AND OPERATING RESULTS AND DIRECTOR RESIGNATION

Antibe Therapeutics Inc. has filed its financial and operating results for the fiscal quarter ended Dec. 31, 2014. The corporation's unaudited third quarter 2015 financial statements and management's discussion and analysis are available on SEDAR.

The company also announced that Jonathan Ross Goodman has resigned from the company's board of directors, effective today. Mr. Goodman has been a director since June, 2013. Samira Sakhia will replace Mr. Goodman as chair of the audit committee.

Mr. Goodman stated: "It has been a pleasure working with Antibe's management and board. They are an extremely talented group. My duties at Knight Therapeutics are simply too great to continue these additional responsibilities. I look forward to remaining connected with the team."

"Antibe's management and shareholders would like to thank Jonathan for his contributions to the company, the board and its shareholders. We look forward to maintaining a close working relationship with Jonathan and his business enterprises, and are grateful that he has offered continued assistance," said Walt Macnee, chairman of Antibe's board of directors.